Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

RSS icon

A 'moving target': PCPs call out inconsistent regulations in the rollout of telehealth

These regulations varied between states and insurance plans, and they affected reimbursement as well.

patient acceptance of medical AI is rising

Is crafty ‘Dr. AI’ already siphoning mindshare from actual doctors?

Patients can be persuaded to place almost as much confidence in diagnostic AI as they have in primary care physicians.

Thumbnail

How age, gender and medical specialty affect a physician's risk of being sued

New data from the American Medical Association reveal that nearly one-third of physicians in the United States have been sued during their medical career. 

Thumbnail

1 in 3 cardiologists have been sued, though they often win when it happens

Overall, 31.2% of U.S. physicians say they have been sued. When looking at only cardiologists, the percentage is slightly higher.

MAUDE database medical device safety

Risk points revealed in US database of AI-powered medical devices

Researchers analyzed 266 safety events reported to the FDA’s Manufacturer and User Facility Device Experience (“Maude”) program.

Thumbnail

New CMS code could pave the way for coverage of virtual reality-based treatments

The determination places the device under the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) benefit category. 

ChatGPT bests physicians at patient care

AI outplays physicians at informing patients and feeling their pain too

Unexpected empathy: Blinded healthcare professionals consistently scored the AI—yes, a ChatGPT model—higher than the doctors even for bedside manners.

The FDFA has cleared tirzepatide (Mounjaro) from Eli Lilly for the treatment of diabetes.

Eli Lilly targets FDA approval for weight loss medication

Tirzepatide, sold under the name Mounjaro, is among a handful of drugs with big buzz for their weight loss results, and approval for obesity could be a huge revenue source for Eli Lilly in the future.

Displaying 273 - 280 of 573

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup